Vaccine blow as Oxford Covid-19 trial to be re-run after research error
Pharma firm AstraZeneca which is partnering the university admitted the mistake following US reports that its best dosage only worked well in younger people.
Full Article
Vaccine blow as Oxford Covid-19 trial to be re-run after research error
Daily Record
0 shares
1 views
You might like
Related news coverage
Oxford/AstraZeneca Covid vaccine 'dose error' explained
Some trial volunteers were given shots half the planned strength, so how does that affect the results?
BBC News
Doubts raised over AstraZeneca-Oxford vaccine data
Oxford university acknowledges error that forced trial to switch dosing regimens
FT.com